Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Giulia Demarzo

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drugs & Aging|May 31, 2022
Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, et al.
Drug Design, Development and Therapy|April 28, 2021
Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-ArtVincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical RemissionGiorgia Bodini, Andrea Ghezzi, Andrea Pasta, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 31, 2019
A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel diseaseGiorgia Bodini, Claudia Zanella, Mattia Crespi, et al.
Patient Preference and Adherence|March 30, 2023
Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral CenterAnna Viola, Maria Giulia Demarzo, Alfredo Abbruzzese, et al.
Annals of Hepatology|January 3, 2019
Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting AntiviralsMattia Crespi, Maria Giulia Demarzo, Matteo Brunacci, et al.
Scandinavian Journal of Gastroenterology|September 26, 2019
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseaseGiorgia Bodini, Maria Giulia Demarzo, Margherita Saracco, et al.
European Journal of Clinical Investigation|January 24, 2025
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trialAndrea Pasta, Elena Formisano, Francesco Calabrese, et al.
Diseases (Basel, Switzerland)|November 26, 2024
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn's Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort StudiesAndrea Pasta, Francesco Calabrese, Elisa Marabotto, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2020
Esophageal reflux hypersensitivity: Non-GERD or still GERD?Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drugs & Aging|May 31, 2022
Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, et al.
Drug Design, Development and Therapy|April 28, 2021
Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-ArtVincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical RemissionGiorgia Bodini, Andrea Ghezzi, Andrea Pasta, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 31, 2019
A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel diseaseGiorgia Bodini, Claudia Zanella, Mattia Crespi, et al.
Patient Preference and Adherence|March 30, 2023
Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral CenterAnna Viola, Maria Giulia Demarzo, Alfredo Abbruzzese, et al.
Annals of Hepatology|January 3, 2019
Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting AntiviralsMattia Crespi, Maria Giulia Demarzo, Matteo Brunacci, et al.
Scandinavian Journal of Gastroenterology|September 26, 2019
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseaseGiorgia Bodini, Maria Giulia Demarzo, Margherita Saracco, et al.
European Journal of Clinical Investigation|January 24, 2025
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trialAndrea Pasta, Elena Formisano, Francesco Calabrese, et al.
Diseases (Basel, Switzerland)|November 26, 2024
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn's Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort StudiesAndrea Pasta, Francesco Calabrese, Elisa Marabotto, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2020
Esophageal reflux hypersensitivity: Non-GERD or still GERD?Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, et al.
Pageof 2